Intellectual property position: AnelleO IVR technology is covered by an expanding Intellectual Property portfolio, including license rights to IP generated at the University of North Carolina at Chapel Hill.
Through our relationship with Carbon, Inc., AnelleO uses a state-of-the-art 3D printing technology, utilizing digital light synthesis (DLS) – a novel 3D printing process (CLIP™)– for rapid, cost-effective manufacturing of geometrically variable (design, surface area, size, compression) intravaginal rings as platforms for drug delivery.
AnelleO makes IVRs with complex geometries that offer precise and tunable control over drug release kinetics. This tunable control also impacts the total amount of drug released, which can be > 90% of the total drug loaded into the drug-device.
Our technology and manufacturing process includes patent-pending drug incorporation methods that are compatible with polar and nonpolar small and large molecules including biologics. We can match IVRs from our library to pharma’s target molecules to create the optimum delivery platform in months, not years.
Our process is scalable to meet research, development and commercial needs.
AnelleO is harnessing the advancements in the speed and scale of 3D printing technology for novel solutions in Women’s Health. AnelleO’s first products are Intravaginal Rings (IVRs), which offer a unique platform for sustained delivery of therapeutics – a non-invasive, self-administered and retrievable platform that can deliver drugs over a period of days to months.
Contact us at: [email protected]
Legal Information:
Conflict of Interest Policy